LWCFA
ONC

Loring Wolcott & Coolidge Fiduciary Advisors’s BeOne Medicines Ltd ONC Stock Holding History

Loring Wolcott & Coolidge Fiduciary Advisors’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-9
Closed -$3K – 778
2021
Q3 		$3K Hold
9
– – ﹤0.01% 697
2021
Q2 		$3K Buy
+9
New +$2.98K ﹤0.01% 829

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

Loring Wolcott & Coolidge Fiduciary Advisors's ONC Position: Q4 2021 in Review

Loring Wolcott & Coolidge Fiduciary Advisors sold out of BeOne Medicines Ltd (ONC) in Q4 2021, closing a stake of 9 shares — an estimated $3K sold.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in ONC in Q2 2021 and held it in 2 quarters. The position peaked at $3K in Q3 2021. 263 funds tracked by Wall St. Rank hold ONC as of Q4 2021.

  • Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining BeOne Medicines Ltd position as of Q4 2021 after selling out during the quarter.
  • Loring Wolcott & Coolidge Fiduciary Advisors sold 9 BeOne Medicines Ltd shares in Q4 2021, an estimated $3K.
  • Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in BeOne Medicines Ltd in Q2 2021 and held it in 2 quarters.
  • Loring Wolcott & Coolidge Fiduciary Advisors's BeOne Medicines Ltd position peaked at $3K in Q3 2021.
  • 263 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2021.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.